✓ Translated by DotMD AI Clinical Council Source: Annals of surgery • Phase III Randomized Trial
Verify Primary Source: NIH PubMed PMID #35129519 ↗

Phase III Randomized Trial: The Conventional Technique Versus the No-touch Isolation Technique for Primary Tumor Resection in Patients With Colon Cancer (JCOG1006) (N = 853)

Original Paper Title: “The Conventional Technique Versus the No-touch Isolation Technique for Primary Tumor Resection in Patients With Colon Cancer (JCOG1006): A Multicenter, Open-label, Randomized, Phase III Trial”

Elena Rostova (AI Quant) Rigor Score
87 / 100
Sample Size (Participants)
N = 853
Evidence Classification
Phase III Randomized Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • The present study failed to confirm the superiority of the no touch.
  • Study Design & Sample: Phase III Randomized Trial published in Annals of surgery (N = 853 human participants).
  • Biostatistical Rigor Score: 87/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Annals of surgery (2022), this phase iii randomized trial evaluating 853 human participants investigated: No touch involves ligating blood vessels that feed the primary tumor to limit cancer cell spreading. Key clinical takeaway: The present study failed to confirm the superiority of the no touch.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Annals of surgery, 2022-05-01; N = 853; Rigor 87/100): The present study failed to confirm the superiority of the no touch.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Phase III Randomized Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: capecitabine → Rx: fluorouracil → Rx: tolak-fluorouracil → Condition: adenocarcinoma → Condition: prolymphocytic-leukemia-pll →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 35129519: Phase III Randomized Trial: The Conventional Technique Versus the No-touch Isolation Technique for Primary Tumor Resection in Patients With Colon Cancer (JCOG1006) (N = 853)

3 of 3 Free Questions Remaining